Wild Bird Therapeutics Hong Kong Limited had the opportunity to present its company, mission and strategic vision to a delegation of Spanish entrepreneurs, executives and professionals visiting Hong Kong and Shenzhen as part of an innovation program led by Eseune Business School.
The presentation took place at the Hong Kong-Shenzhen Innovation and Technology Park, a strategic location within the Greater Bay Area and a key platform for cross-border innovation between Hong Kong and Shenzhen.
During the session, Wild Bird Therapeutics introduced its approach to accelerating next-generation oncology therapeutics through the integration of artificial intelligence, molecular dynamics, biophysics and translational science.
The visit also provided an opportunity to discuss future collaboration between European companies, scientific teams and the Hong Kong-Shenzhen innovation ecosystem, particularly in biotechnology, drug discovery and AI-driven life sciences.
Wild Bird Therapeutics appreciates the delegation’s interest and the opportunity to share its work within one of Asia’s most dynamic innovation environments.